Evidence map›Paper›PMID 23926352›Full record

ArticleJournal of virology2013

Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization.

Emily A Sloan, Mary F Kearney, Laurie R Gray, Kathryn Anastos, Eric S Daar, Joseph Margolick, Frank Maldarelli, Marie-Louise Hammarskjold, David Rekosh

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Measurement of HIV Rev-Rev Response Element Functional Activity.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. HIV-based lentiviral vectors: origin and sequence differences.Molecular therapy. Methods & clinical development · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Emily A SloanDepartment of Microbiology, Immunology and Cancer Biology and The Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia, Charlottesville, Virginia, USA.
Mary F Kearney
Laurie R Gray
Kathryn Anastos
Eric S Daar
Joseph Margolick
Frank Maldarelli
Marie-Louise Hammarskjold
David Rekosh
University of Virginia · USFrederick National Laboratory for Cancer Research · USHarbor–UCLA Medical Center · USJohns Hopkins University · USMontefiore Medical Center · USNational Cancer Institute · US

Funding

Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
HIV-1 Genetic Variation in Infected IndividualsZIABC010819 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MALDARELLI, FRANK · 2009 to 2025
$9.9M
Compounds That Inhibit HIV Rev FunctionR01AI068501 · NIAID · UNIVERSITY OF VIRGINIA · PI REKOSH, DAVID M · 2006 to 2008
$1.3M
Functional Variation of Rev and RRE Activity During HIV InfectionR01GM110009 · NIGMS · UNIVERSITY OF VIRGINIA · PI HAMMARSKJOLD, MARIE-LOUISE, REKOSH, DAVID M · 2013 to 2016
$1.2M
HIV Rev/RRE Variation and ConstraintsR21AI087505 · NIAID · UNIVERSITY OF VIRGINIA · PI REKOSH, DAVID M · 2010 to 2011
$417k
NCATS NIH HHS UL1 TR000124NIAID NIH HHS AI068501NIAID NIH HHS AI087505NIAID NIH HHS R01 AI068501NIAID NIH HHS R21 AI087505NIAID NIH HHS T32 AI007046NIAID NIH HHS U01 AI035004NIAID NIH HHS UO1-AI-35004NIGMS NIH HHS R01 GM110009
6 · The paper itself

Abstract

HIV-1 Rev and the Rev response element (RRE) enable a critical step in the viral replication cycle by facilitating the nuclear export of intron-containing mRNAs, yet their activities have rarely been analyzed in natural infections. This study characterized their genetic and functional variation in a small cohort of HIV-infected individuals. Multiple Rev and RRE sequences were obtained using single-genome sequencing (SGS) of plasma samples collected within 6 months after seroconversion and at a later time. This allowed the identification of cognate sequences that were linked in vivo in the same viral genome and acted together as a functional unit. Phylogenetic analyses of these sequences indicated that 4/5 infections were founded by a single transmission event. Rev and RRE variants from each time point were subjected to functional analysis as both cognate pairs and as individual components. While a range of Rev-RRE activities were seen, the activity of cognate pairs from a single time point clustered to a discrete level, which was termed the set point. In 3/5 patients, this set point changed significantly over the time period studied. In all patients, RRE activity was more sensitive to sequence variation than Rev activity and acted as the primary driver of the cognate set point. Selected patient RREs were also shown to have differences in Rev multimerization using gel shift binding assays. Thus, rather than acting as a simple on-off switch or maintaining a constant level of activity throughout infection, the Rev-RRE system can fluctuate, presumably to control replication.

Indexed as

Genes, envMutationVirus ReplicationAdultCluster AnalysisFemaleHIV-1HIV InfectionsHumansMaleMiddle AgedPhylogenyPlasmarev Gene Products, Human Immunodeficiency VirusRNA, ViralSequence Analysis, DNArev Gene Products, Human Immunodeficiency Virusrev protein, Human Immunodeficiency Virus-1RNA, Viral

Identifiers

PMID23926352
PMCPMC3807272
OpenAlexW2111623022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.